Skip to main content
Journal cover image

Predictors of death and reinfarction at 30 days after primary angioplasty: the GUSTO IIb and RAPPORT trials.

Publication ,  Journal Article
Brener, SJ; Ellis, SG; Sapp, SK; Betriu, A; Granger, CB; Burchenal, JE; Moliterno, DJ; Califf, RM; Topol, EJ
Published in: Am Heart J
March 2000

BACKGROUND: Thirty-day death among recipients of fibrinolytic therapy for acute myocardial infarction (MI) is tightly correlated with easily obtainable key demographic and clinical parameters such as age, blood pressure, heart rate, and infarct location. Similar data for primary angioplasty are not available. METHODS AND RESULTS: Data from 2 large, contemporary, primary angioplasty trials were formally combined and analyzed with respect to death and death/repeat MI at 30 days through the use of multivariate logistic regression models. The 1048 patients had a median age of 62 years, and 26% were women. Thirty-eight percent had an anterior infarction. The patients underwent angioplasty at a median delay from symptom onset of 3.8 hours. Death was independently predicted by increasing age (adjusted odds ratio [OR] per decade 2.32, 95% confidence interval [CI] 1.60 to 3.42), whereas a history of smoking (OR 0.29, CI 0.13 to 0.64), Thrombolysis in Myocardial Infarction (TIMI) flow grade 3 after angioplasty (OR vs TIMI <3 0.21, CI 0.10 to 0.45) and higher systolic blood pressure (OR per 10 mm Hg 0.73, CI 0.62 to 0. 87) were associated with lower mortality rates. Death or repeat MI was independently associated with increasing age (OR per decade 1.40, CI 1.13 to 1.76) and anterior location of the index MI (OR 1.89, CI 1.12 to 3.20). TIMI grade 3 flow (OR vs TIMI <3 0.40, CI 0.23 to 0. 68) and higher systolic blood pressure (OR per 10 mm Hg 0.79, CI 0. 71 to 0.89) were associated with a lower incidence of death/repeat MI. Time to angioplasty, heart rate, extent of coronary artery disease, participation in 1 of the 2 trials, and all common coronary risk factors did not significantly predict outcome. CONCLUSIONS: Death and reinfarction after primary angioplasty are predominantly predicted by age, hemodynamic instability, and the attainment of TIMI 3 flow in the infarct artery.

Duke Scholars

Published In

Am Heart J

DOI

ISSN

0002-8703

Publication Date

March 2000

Volume

139

Issue

3

Start / End Page

476 / 481

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Thrombolytic Therapy
  • Survival Rate
  • Smoking
  • Sex Distribution
  • Risk Factors
  • Randomized Controlled Trials as Topic
  • Prospective Studies
  • Odds Ratio
  • Myocardial Infarction
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Brener, S. J., Ellis, S. G., Sapp, S. K., Betriu, A., Granger, C. B., Burchenal, J. E., … Topol, E. J. (2000). Predictors of death and reinfarction at 30 days after primary angioplasty: the GUSTO IIb and RAPPORT trials. Am Heart J, 139(3), 476–481. https://doi.org/10.1016/s0002-8703(00)90091-7
Brener, S. J., S. G. Ellis, S. K. Sapp, A. Betriu, C. B. Granger, J. E. Burchenal, D. J. Moliterno, R. M. Califf, and E. J. Topol. “Predictors of death and reinfarction at 30 days after primary angioplasty: the GUSTO IIb and RAPPORT trials.Am Heart J 139, no. 3 (March 2000): 476–81. https://doi.org/10.1016/s0002-8703(00)90091-7.
Brener SJ, Ellis SG, Sapp SK, Betriu A, Granger CB, Burchenal JE, et al. Predictors of death and reinfarction at 30 days after primary angioplasty: the GUSTO IIb and RAPPORT trials. Am Heart J. 2000 Mar;139(3):476–81.
Brener, S. J., et al. “Predictors of death and reinfarction at 30 days after primary angioplasty: the GUSTO IIb and RAPPORT trials.Am Heart J, vol. 139, no. 3, Mar. 2000, pp. 476–81. Pubmed, doi:10.1016/s0002-8703(00)90091-7.
Brener SJ, Ellis SG, Sapp SK, Betriu A, Granger CB, Burchenal JE, Moliterno DJ, Califf RM, Topol EJ. Predictors of death and reinfarction at 30 days after primary angioplasty: the GUSTO IIb and RAPPORT trials. Am Heart J. 2000 Mar;139(3):476–481.
Journal cover image

Published In

Am Heart J

DOI

ISSN

0002-8703

Publication Date

March 2000

Volume

139

Issue

3

Start / End Page

476 / 481

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Thrombolytic Therapy
  • Survival Rate
  • Smoking
  • Sex Distribution
  • Risk Factors
  • Randomized Controlled Trials as Topic
  • Prospective Studies
  • Odds Ratio
  • Myocardial Infarction